[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
21
5.1kṀ5857Dec 31
27%
chance
1H
6H
1D
1W
1M
ALL
Resolves according to Metaculus resolution.
Metaculus high-level description:
This question will resolve as Yes if any of the US FDA, UK MHRA, or the EU Commission authorizes the use or sale of a therapy whose primary mechanism directly editing the patient's genomic DNA for any human condition other than sickle cell disease and beta thalassemia before January 1, 2027.
Esta pergunta é gerenciada e resolvida pela Predita.
Get 
1,000 to start trading!
1,000Pessoas também estão operando
Perguntas relacionadas
When will commercial gene-editing therapy be available?
2041
[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
19% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
79% chance
By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
18% chance
Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027?
59% chance
[Metaculus] Before 2032, will a vaccine against HIV-1 be approved by the USA, UK, EU, or Canada?
76% chance
Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?
Where will human germline gene editing resulting in a live birth first occur legally?
Will we have gene therapy for a major strain of Crohn's disease by 2030?
26% chance
In which year will the first baby be born as the result of legal germline gene editing?